Wells Fargo’s Can-Fite BioPharma CANF Stock Holding History
Bought
Maintained
Sold
| Quarter | Market Value | Status | Shares |
Shares Change % | Capital Flow | Portfolio Weight | Portfolio Position | |
|---|---|---|---|---|---|---|---|---|
|
2025
Q2 | $2.84K | Hold |
2,700
| – | – | ﹤0.01% | 5701 |
|
|
2025
Q1 | $4K | Buy |
2,700
+200
| +8% | +$296 | ﹤0.01% | 5590 |
|
|
2024
Q4 | $4.06K | Hold |
2,500
| – | – | ﹤0.01% | 5592 |
|
|
2024
Q3 | $5.03K | Buy |
+2,500
| New | +$5.03K | ﹤0.01% | 5505 |
|
|
2022
Q2 | – | Sell |
-150
| Closed | -$2K | – | 6534 |
|
|
2022
Q1 | $2K | Hold |
150
| – | – | ﹤0.01% | 6297 |
|
|
2021
Q4 | $2K | Hold |
150
| – | – | ﹤0.01% | 6309 |
|
|
2021
Q3 | $2K | Hold |
150
| – | – | ﹤0.01% | 6221 |
|
|
2021
Q2 | $3K | Hold |
150
| – | – | ﹤0.01% | 6105 |
|
|
2021
Q1 | $4K | Buy |
+150
| New | +$4K | ﹤0.01% | 6161 |
|